New study reveals hidden blood flow dynamics when reducing shock medications
NCT ID NCT07653659
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study observes 30 adults with distributive shock who are on a ventilator and receiving norepinephrine to maintain blood pressure. Researchers measure critical closing pressure—the pressure at which small blood vessels collapse—before and 30 minutes after doctors reduce the norepinephrine dose. The goal is to understand how these changes affect tissue perfusion and guide safer medication management in intensive care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors better understand how to safely reduce blood pressure medications in shock patients, potentially improving recovery.
What could go wrong
This is a small observational study with only 30 participants, so results may not apply to all patients. It does not test a new treatment, only measures existing care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, 100730, China
Contact Phone: •••-•••-•••• Email: •••••@•••••